lenalidomide,rituximab,acalabrutinib
astrazeneca
['lenalidomide', 'ritux', 'acalabrutinib', 'lymphoma']
great to see #mcl #lymphoma treated first-line with a non-#chemo triplet - #rituximab, #lenalidomide and #acalabrutinib - with 83% of patients achieving #cr with undetectable #mrd. j ruan. #ash22
Cancer specialist searching the world for better therapy